MAP3K7 and metabolic dysfunction-associated steatohepatitis: 5Z-7-oxozeaenol slows the progression of Nonalcoholic steatohepatitis by inhibiting the activation of the mitogen-activated protein kinase (MAPK) signaling pathway via suppressing TAK1 (94).